GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioelife LITH · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2018

Net income

−$336,958

FY2014FY2018

Free cash flow

−$76,691

FY2014FY2018

Shareholders' equity

−$325,160

FY2014FY2018

Income statement

Fiscal years

FY2018FY2017FY2016FY2015FY2014
Gross profit−$800−$800−$1,775—−$396,000
Operating income−$73,743−$125,059−$103,964−$61,352−$463,619
Net income−$336,958−$246,858−$209,513−$82,187−$498,326
Diluted earnings per share-0.13-0.09-0.08-0.03-0.19

Balance sheet

At each fiscal year end

FY2018FY2017FY2016FY2015FY2014
Total assets$140,006$376,535$31,422$1,389$256
Total liabilities$465,166$447,147$321,723$219,195$368,530
Debt————$259,482
Shareholders' equity−$325,160−$70,612−$290,301−$217,806−$368,274
Shares outstanding3m3m3m3m3m

Cash flow

Fiscal years

FY2018FY2017FY2016FY2015FY2014
Cash from operations−$76,071−$122,050−$129,404−$33,367−$36,783
Capital spending−$620−$620−$4,445−$4,445−$4,445
Free cash flow−$76,691−$122,670−$133,849−$37,812−$41,228

Latest quarters

By quarter end

Sept 2019Jun 2019Mar 2019Dec 2018Sept 2018Jun 2018Mar 2018Dec 2017
Gross profit−$1,152−$296−$47−$800———−$800
Operating income−$20,799−$21,949−$26,085−$22,160−$16,732−$18,777−$152−$60,050
Net income−$48,410−$106,155$80,295−$515,417$37,659$190,899−$473−$90,486
Diluted earnings per share-0.02-0.040.03-0.200.010.07-0.00-0.03
Total assets$47,881$112,437$219,443$140,006$642,134$592,229$3,553$376,535
Debt——————$2,378$277,827
Shareholders' equity$6,927$55,337−$244,865−$325,160$190,257$152,598−$362−$70,612

Growth per year

Compound annual rate

3 years5 years10 years
Operating income6.3%1.8%4.0%
Net income60.1%38.1%21.0%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return100%0%100%1400%-79%278%129%-12%-20%1565%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 40-to-1 reverse split · 4 Dec 2018
  • 7-for-1 split · 24 Apr 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.